Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

Natalie Grover

Reporter

Zoetis forked over $85 million in 2017 to acquire Nexvet Biopharma and its pipeline of monoclonal antibodies. Juergen Horn, Nexvet’s former chief product development officer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

Natalie Grover

Reporter

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Trump says he'll sign order on 'most-favored nation' drug price plans Monday

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

Revolution’s KRAS drugs appear competitive in several lung cancer settings

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

An­i­mal health vet Juer­gen Horn makes new an­ti­body play for pets, rak­ing $15M in Se­ries A haul

Reporter

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul